Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I see a major like Canopy $WEED wanting to takeout VNNYF now....
Read below articles and think of VNNYF after reading it: CONNECT THE DOTS HERE....
Vinergy(MJ Biopharma) Is now making more money and is more profitable than Canopy.!!! Yet we are at 27 million market cdn...
VINERGY DEAL:
* Shipped over 35,000,000 plant products to the global marketplace
* Vinergy now has access to an extensive catalogue of over 2000 hemp and cannabis strains with the ability to supply those strains to customers globally.
* the Target has the capacity to expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe.
"Our goal has always been to control every step of the production process from genetics, right through to extraction, ensuring only the highest quality extracts are used in the formulation of our strips, time release capsules and other products currently under development for the medical and recreational cannabis space," added Mr. Deuters. The Company will aim to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains.
The marijuana push within the company comes with an existing cannabis license, an export license, and strong interest from the growing EU market for cannabis and CBDs.
German cannabis market could be significant for Canopy Growth Corp, says PI
Canopv will realize the additional margin and also have the ability to obtain a cultivation license in the future
German cannabis market could be significant for Canopy Growth Corp, says PI
Canopy Growth enters German marijuana market
[url]
http://marijuanapolitics.com/germany-is-poised-to-be-a-powerful-cannabis-market/[/url][tag]Germany Is Poised to Be a Powerful Cannabis Market[/tag]
Canadian Licensed Medical Cannabis Producers Bounce Back
Although yesterday’s trading activity within the cannabis sector was mixed, certain sub-sectors performed better than other and we are monitoring this activity closely. Canadian licensed medical cannabis producers saw strength yesterday and each member of the Big Five (Canopy Growth, OrganiGram, Aphria, Aurora, and Mettrum) ended the day in positive territory.
Yesterday, Emblem Corp (EMC.V) lived up to the hype during its initial public offering as trading activity exceeded our already high expectations. Emblem is a licensed medical cannabis producer in Canada uniquely positioned within the rapidly growing medical and recreational cannabis industry.
We are favorable on Emblem for the following reasons: 1) The company operates three distinct divisions which can create value for each other, 2) Its initial public offering saw remarkably high interest from the marketplace, 3) Its Emblem Cannabis division started selling medical cannabis in August and we expect to see continued growth on a month-over-month basis, and 4) It is led by a management team that has a proven track record of building successful multi-billion dollar companies.
Great read here:
Emblem Corp. (TSX-V: EMC)
How to Invest in Marijuana
Conclusion
There are a handful of marijuana stocks out there, but Emblem is unique.
Sure, they are a licensed producer with the capacity to expand and produce as much as some of the biggest licensed producers in Canada.
Sure, they can make millions of dollars growing and selling marijuana.
But Emblem has what no other company has.
It has John Stewart.
Together with his team of healthcare professionals, John could lead Emblem into a whole new category of pain management therapies.
Imagine being able to invest in Tylenol or Advil when they were first introduced into the market.
Yes, marijuana pharmaceuticals are in its infancy, but that’s precisely why we could witness explosive growth.
So regardless of whether recreational marijuana laws pass in Canada, Emblem could still benefit from growth in the coming years with its pharmaceutical division.
Emblem isn’t just another licensed producer listed on a stock exchange and reaping the rewards of a hot sector.
Emblem is a fully integrated Canadian healthcare and pharmaceutical company led by a team of healthcare and Big Pharma executives.
The last financing was done at $1.15, so I expect that’s likely where the stock will open. But where it opens and where it ends up is a completely different ball game.
I expect a frenzy of buying coming into this Company the moment it begins to trade, based on how undervalued it is when compared to its peers and the team leading the charge.
While the legalization of recreational marijuana is still up in the air, we’re expected to get a glimpse of what the government wants to do next week.
If the report is positive towards the path of legalization across Canada, we could be in for another explosion of buyers into the sector.
If that happens, I don’t expect Emblem will be trading at its current EV for long.
Seek the truth,
Ivan Lo
Great read here:
Emblem Corp. (TSX-V: EMC)
How to Invest in Marijuana
Conclusion
There are a handful of marijuana stocks out there, but Emblem is unique.
Sure, they are a licensed producer with the capacity to expand and produce as much as some of the biggest licensed producers in Canada.
Sure, they can make millions of dollars growing and selling marijuana.
But Emblem has what no other company has.
It has John Stewart.
Together with his team of healthcare professionals, John could lead Emblem into a whole new category of pain management therapies.
Imagine being able to invest in Tylenol or Advil when they were first introduced into the market.
Yes, marijuana pharmaceuticals are in its infancy, but that’s precisely why we could witness explosive growth.
So regardless of whether recreational marijuana laws pass in Canada, Emblem could still benefit from growth in the coming years with its pharmaceutical division.
Emblem isn’t just another licensed producer listed on a stock exchange and reaping the rewards of a hot sector.
Emblem is a fully integrated Canadian healthcare and pharmaceutical company led by a team of healthcare and Big Pharma executives.
The last financing was done at $1.15, so I expect that’s likely where the stock will open. But where it opens and where it ends up is a completely different ball game.
I expect a frenzy of buying coming into this Company the moment it begins to trade, based on how undervalued it is when compared to its peers and the team leading the charge.
While the legalization of recreational marijuana is still up in the air, we’re expected to get a glimpse of what the government wants to do next week.
If the report is positive towards the path of legalization across Canada, we could be in for another explosion of buyers into the sector.
If that happens, I don’t expect Emblem will be trading at its current EV for long.
Seek the truth,
Ivan Lo
Namaste Announces Record Monthly Sales of Over $1.0 Million and 1,308% Increase in Traffic
WoW !!! These numbers are amazing
Do the math people...Namaste is only going to get bigger, get more trafic, make more sales...
Imagine with eBay and now tselling the new PAX etc....
Other companies with these numbers are 40x Namaste valuation...
Just a few AGS Revenue opportunities....$$
Arcturus Acquires Revenue Generating App Portfolio Marking its First Acquisition in Mobile Agriculture Technology
* It also positions the Company to receive consistent monthly income, as the App Portfolio's trailing 12-month EBITDA was USD $139,000 or CDN $183,000.
* "For the month of September, the All-In-One App Portfolio revenue grew by 50%, serving up over 57,000 Facebook ad impressions and over 26,000 AdMob impressions, which puts us at an annual run rate of almost 1,000,000 ads for the next 12 months
Arcturus Establishes a New 420AppGaming Division Entering the $37 Billion Dollar Mobile Gaming Market
* is pleased to announce that it has established a new mobile gaming division (www.420AppGaming.com) with the intent to put out 420 themed games, which will generate revenue through In App Purchases (IAP) as well as through ad impressions.
* "With our recent mobile app acquisition and our growing focus on Cannabis, we feel Arcturus is now uniquely positioned to capitalize on these two huge and converging trends by publishing a suite of 420 themed games and utility apps,"
Arcturus to Acquire Established Florida Greenhouse Zoned for Medical Marijuana
* In the past 12 months, it has generated over $2,600,000 in revenue with EBITDA of over $400,000, which is expected to continue until Amendment 2 allows for the property to be converted for growing cannabis.
* Once fully licensed and operational, the property has the capacity to generate seven figures in revenue per month.
* In the interim we feel we can use our CEA technology to quadruple the current ornamental plant yields, thereby increasing both profit and revenue."
Arcturus to Acquire 15-Acres of Cannabis Zoned Land
* 15-acre parcel of land in Redland, Florida, in a county that is designated to legally cultivate, process and dispense cannabis.
* we want to be firmly established in the state and solidify our first mover advantage in one of the biggest potential cannabis markets in the United States
* With this acquisition and the previously announced 10-acre greenhouse acquisition near Orlando, Arcturus has the potential, if fully licensed, to develop 25-acres of cannabis crops. If current state projections for the cannabis market size hold up to their $1.8B projection by 2020, Florida will have considerable demand for medical marijuana, even without factoring in the potential for recreational legislation
Arcturus Led Canada Division Receives New Purchase Orders and Begins ETL Certification for its Award Winning Cannabis Grow Lights
* This one customer positions LED Canada, a wholly owned Arcturus division, to potentially generate over $1,000,000 in business in 2017
* “This month the Company shipped its largest single order to a single commercial customer, which operates a chain with 200 locations. The customer is currently testing the LED lighting in key markets and structuring a rollout to its other locations throughout Canada.”
* Arcturus’ LED division reports that the month of November has been the best sales month to date.
* The Company is looking forward to continuing its momentum in 2017 with the rollout of new LED testing results, plus new sales and marketing initiatives.
* “In addition to third party testing, it is expected that the Company will be gaining ETL certification in the next 60 days, opening up the entire North American marketplace, which we believe will have a very positive effect on sales for Arcturus’ COB Grow Lights and LED Canada’s sales in 2017.”
AGS becoming a leader in the marijuana technology
Other Canadian Stocks
Arcturus Growthstar Technologies (AGS) is an indoor plant growth technology company whose patented vertical farming technology generates yields up to ten times greater per square foot of land when compared to traditional plant production methods, Spatafora said.
"We believe this company could be on its way to becoming a leader in the marijuana technology and infrastructure support niche," he said. "Their experienced management team focuses on leveraging cash flows to make very selective and accretive acquisitions while developing and scaling their existing portfolio."
Namaste Approved to Distribute Through eBay
VANCOUVER, BRITISH COLOMBIA--(Marketwired - Nov. 29, 2016) - Namaste Technologies Inc. ("Namaste" or the "Company") (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ) is pleased to announce that it has been approved to distribute its products through eBay Inc. ("eBay"), a global commerce leader that connects millions of buyers and sellers around the world. As one of a select number of companies in the vaporizers and accessories industry to be permitted to distribute through eBay's marketplace, Namaste will list its products under the recently launched vaporizers and e-cigarettes category.
Namaste will be required to keep sufficient product inventory on hand in the anticipation of increased demand through eBay's marketplace and ensure adherence to all applicable category policies.
Management Commentary
Sean Dollinger, President and CEO of Namaste, comments: "We are very pleased to be one of a select few companies in our industry to be permitted to distribute our products through eBay. As a household name, we are also pleased to see the launch of a new product category from eBay to specifically address the growing demand for our products. We anticipate being able to significantly increase sales through the eBay marketplace."
About eBay Inc.
eBay Inc. is a global commerce leader that includes Marketplace, StubHub and Classifieds platforms. Collectively, the platforms connect millions of buyers and sellers around the world. The technologies and services that power these platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it virtually anytime and anywhere. The Marketplace platforms include the online marketplace located at www.ebay.com, its localized counterparts and the eBay mobile apps; which are among the world's largest and most vibrant marketplaces for discovering great value and unique selection.
About Namaste Technologies Inc.
Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.
On behalf of the Board of Directors
Sean Dollinger, Chief Executive Officer
Further information on the company and its products can be accessed through the link below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.vaporseller.com
www.everyonedoesit.com
www.everyonedoesit.co.uk
Reliq Health Technologies Announces Patient Enrollment at Sacred Heart Health System in Florida for Pilot to Reduce Readmissions and Improve Health Outcomes for Congestive Heart Failure Patients
This morning, Reliq Health Technologies (RHT.V or RQHTF) announced the enrollment of patients at Sacred Heart Health System in Florida, in connection with its previously announced Pilot.
Key News Highlights:
1) This marks the second major patient enrollment of remote patient monitoring and care collaboration solution out of the four signed and announced pilots for Reliq Health Technologies to date (Sacred Heart in Florida, the Feldman Institution in Louisiana, NHS in London UK, and HHS in Hamilton Ontario);
2) The goal of this pilot is to demonstrate the value of Reliq Health’s self-care solution in improving health outcomes and reducing the cost of readmissions for Congestive Heart Failure (CHF) Patients.
3) CHF affects over 6 Million Americans and 21% of all CHF patients in the US who are admitted to a hospital will be readmitted within 30 days of discharge. Currently this type of readmission (for all hospital patients) cost the US healthcare system over $41 Billion annually;
4) Sacred Heart Health System #s in 2015:
a. Reported over $2 Billion USD in total patient revenue
b. They saw over 100,000 patients in their emergency rooms
c. Admitted over 30,000 patients
d. Performed over 15,000 surgeries
e. Over 4,000 employees
* 15% of Sacred Heart’s patients are admitted and/or receive surgery for cardiac issues, which is the primary target of our pilot with them
5) Sacred Heart is part of Ascension Health, the US's largest system of Catholic and non-profit health care facilities.
6) With the progression towards the successful completion of multiple pilots, Reliq is increasing the pipeline to achieve significant recurring revenue in 2017 while creating a robust, tested, and proven platform with multiple key healthcare areas.
CHF is just the start, with minor customization Reliq’s unique digital health solution, which creates a fully automated “virtual hospital ward” in the patient’s home, can be used by any patient to improve their health outcome, quality of life, and reduce healthcare cost (oncology, post-surgical, diabetes, COPD, palliative care, dementia, etc.).
Namaste Signs Exclusive Distribution Agreement for Inhalater Products
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 16, 2016) - Namaste Technologies Inc. ("Namaste" or the "Company") (CSE:N)(FRANKFURT:M5BQ) is pleased to announce that it has entered an exclusive distribution agreement (the "Agreement") with Pharmacor Technologies Inc.
("Pharmacor") for the international sale of the Inhalater line of vaporizers and accessories. This Agreement represents one of multiple exclusive agreements the Company intends to pursue and is testament to the unique international distribution network and level of service the Company is known for delivering.
Inhalater Line of Products
Inhalater vaporization technology is the result of over 10 years of research and development and comprises a unique dual heating system that offers medicinal grade extraction qualities. This differentiates the products from other vaporizers. Pharmacor is currently releasing the Inhalater S6, which features the following characteristics:
Great taste and effective with flowers, concentrates and shisha tobaccos;
Medical grade device with protective caps and cost effective disposable mouth pieces;
Real-time temperature boost system that enhances vapor production and taste;
Compatible with a range of accessories including water tools, electric grinder to prepare concentrates and capsule pack to carry preloaded doses; and
Over 90 minutes of vaporization time.
The technology is patent pending for all industrialized countries. The Inhalater S6 will retail for approximately $300, which is a competitive price for a premium medical grade vaporizer.
Term of the Agreement
Pursuant to the term of the Agreement, Pharmacor has provided Namaste exclusivity over the sale of the Inhalater line of products for a period of 2 years. The exclusivity shall apply to all countries outside Canada and the US. In exchange for exclusivity, Namaste has committed to use reasonable commercial efforts to build the Inhalater brand internationally and will provide support in terms of managing advertising, shipping, customer service and support, and warranty and return functions. Namaste will charge Pharmacor competitive market rates for managing these services and has established standard operating procedures for administration and execution of the Agreement.
Management Commentary
Sean Dollinger, President and CEO of Namaste, comments: "We are very pleased to be working with Pharmacor to bring their products to the international marketplace. We have built Namaste into a differentiated company based on our extensive international distribution network and our ability to enter agreements with manufacturers to provide specific solutions to take their products to market. We see multiple opportunities to continue expanding our business through exclusive distribution rights."
About Pharmacor Technologies Inc.
Pharmacor technologies is a Canadian based company in operation since 2006. With its first product release in 2012, the company has established itself as a leading entity in the field of medicinal vaporisation. Focused on developing and manufacturing forward thinking technology, Pharmacor combines unique Canadian R&D capacities in the field of cannabis technology with the mass production capacity of Chinese partners. This positions the company as a reference point in the world of vaporization.
About Namaste Technologies Inc.
Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.
On behalf of the Board of Directors
Sean Dollinger, Chief Executive Officer
Further information on the company and its products can be accessed through the links below:
NEWS!!! FARM NO 2! In MIAMI FLORIDA !! Bigger than the other one !!
Arcturus to Acquire 15-Acres of Cannabis Zoned Land
LINK TO NEWS
VANCOUVER, British Columbia, November 15, 2016 /PRNewswire/ --
Arcturus Growthstar Technologies Inc. (AGSTF) (AGS.CN) (the "Company" or "Arcturus") is pleased to announce that it has signed a Letter of Intent ("LOI") to acquire a 15-acre parcel of land in Redland, Florida, in a county that is designated to legally cultivate, process and dispense cannabis. Redland is an unincorporated community within Miami-Dade County, with Biscayne National Park to the east and Everglades National Park to the west. Redland is primarily a Miami suburb and a major agricultural area. Miami-Dade County is referred to as the nation's "Salad Bowl" and "Winter Bread Basket."
"We are pleased to have reached this LOI to acquire this prime parcel of land as it has a long history as a plant nursery, which was first established in 1963," says Mr. William Gildea, Arcturus Growthstar Technologies Inc.'s CEO and Chairman.
"This acquisition will be an all-stock deal and greatly adds to our geographic footprint and overall strategy in the state of Florida. With the recent passage of Amendment 2, an initiative which significantly broadens Florida's medical marijuana program, we want to be firmly established in the state and solidify our first mover advantage in one of the biggest potential cannabis markets in the United States."
With this acquisition and the previously announced 10-acre greenhouse acquisition near Orlando, Arcturus has the potential, if fully licensed, to develop 25-acres of cannabis crops.
If current state projections for the cannabis market size hold up to their $1.8B projection by 2020, Florida will have considerable demand for medical marijuana, even without factoring in the potential for recreational legislation.
This is an exciting acquisition for Arcturus as the 15-acre farm is located in a designated legal grow zone with close proximity to Miami. Arcturus and its experienced team of operators, including John Sweeney, former VP of Operations for Tilray's 60,000-square foot Vancouver facility, is in a unique position as a Canadian based company because it is poised to quickly commence operations within the United States rather than potentially wait years to become a licensed producer under Canadian law.
For further information, contact William Gildea, Director, at 617.834.9467.
On behalf of the Board,
Arcturus Growthstar Technologies Inc.
William Gildea, CEO & Chairman
About Arcturus
Has anybody try doing the numbers on that Florida farm.....with or without cannabis it's huge.
Try doing numbers on 4 + their own build in Rhode Island....
Add to that their 420 cannabis app rev...
Add to that the gaming app rev...
Add to that their #1 cannabis cup award winning commercial lighting and grow supplies
Add to that their worldwide patented vertical farming technology..
This is EXTREMELY undervalued....
AGSTF PRESENTATION
1 farm......7 figures per month....how about X 4.
1 FARM:
In the past 12 months, it has generated over $2.6-million in revenue with earnings before interest, taxes, depreciation and amortization of over $400,000, which is expected to continue until Amendment 2 allows for the property to be converted for growing cannabis. Once fully licensed and operational, the property has the capacity to generate seven figures in revenue per month.
In the interim we feel we can use our CEA technology to quadruple the current ornamental plant yields ($2.6Million x 4 = $10.4Million) , thereby increasing both profit and revenue."
4 MORE FARMS ON THE WAY
oAGT is in advanced discussions with 4 Targeted Projects in the Eastern US
oEach license deal is >$3M
o3 of the 4 are New Market Tax Credit (Federal Government Program) Projects in Partnership with a strategic financial partner
AGS in new article
Arcturus Growthstar Technologies Inc. (AGS: CSE) (AGSTF: OTC) is a company we became more favorable on now that Florida passed a ballot initiative to legalize medical cannabis
A few days before the vote, Arcturus signed a letter of intent to acquire a 10-acre operating greenhouse in a county in Florida that is designated to cultivate, process, and dispense cannabis. The company also said that the greenhouse meets Florida’s criteria for agricultural farmers looking to manufacture cannabis.
Arcturus CEO William Gildea said the property has been family operated since 1959 and currently grows ornamental plants. In the past 12 months, it has generated over $2,600,000 in revenue with EBITDA of over $400,000.
CEO Gildea added, “Once fully licensed and operational, the property has the capacity to generate 7 figures in revenue per month. In the interim we feel we can use our CEA technology to quadruple the current ornamental plant yields, thereby increasing both profit and revenue.”
1 farm......7 figures per month....how about X 4.
1 FARM:
In the past 12 months, it has generated over $2.6-million in revenue with earnings before interest, taxes, depreciation and amortization of over $400,000, which is expected to continue until Amendment 2 allows for the property to be converted for growing cannabis. Once fully licensed and operational, the property has the capacity to generate seven figures in revenue per month.
In the interim we feel we can use our CEA technology to quadruple the current ornamental plant yields ($2.6Million x 4 = $10.4Million) , thereby increasing both profit and revenue."
oAGT is in advanced discussions with 4 Targeted Projects in the Eastern US
oEach license deal is >$3M
o3 of the 4 are New Market Tax Credit (Federal Government Program) Projects in Partnership with a strategic financial partner
They won't issue shares. They will be making money hand over fist, 7 figures a month. Look for debt in regards to acquisitions !!
Marijuana sector eyes U.S. opportunities
A Healthcare Disruptor in a Multi-Billion Dollar Industry
By: Michael Berger — President of Technical420